2027 Genomics & Precision Medicine Award

Unlocking Personalized Care Through Data and Discovery.

The 2027 HealthTechNode Genomics & Precision Medicine Award recognizes technologies, platforms, diagnostics, and care approaches using biological data to make healthcare more individualized, predictive, and effective. This award honors innovations that translate genomic and molecular insight into practical value for patients, clinicians, researchers, and health systems.

Precision medicine can improve how conditions are identified, therapies are selected, risks are understood, and care plans are tailored. Advances in sequencing, biomarkers, clinical decision support, data interpretation, and research infrastructure are helping move personalized care from promise into routine practice.

This award celebrates solutions demonstrating credible science and real-world utility. Strong entries will show how the innovation improves diagnosis, treatment selection, prevention, research, clinical workflows, patient outcomes, or access to precision care.

Entry Schedule

• Entries Open: June 1, 2027
• Early Bird Deadline: June 25, 2027
• Final Entry Deadline: July 23, 2027
• Winners Announced: August 2, 2027

Entry Fees

• Early Bird Entry: $395
• Regular Entry: $495

Who Should Enter

• Companies developing genomic, molecular, biomarker, or precision medicine technologies
• Organizations advancing sequencing, interpretation, diagnostics, or clinical decision support
• Teams using biological and clinical data to personalize prevention, diagnosis, or treatment
• Research and healthcare partners implementing precision medicine programs
• Companies demonstrating measurable scientific, clinical, operational, or patient value

What Judges Will Consider

• Demonstrated value in improving personalized diagnosis, treatment, research, or outcomes
• Strength of the scientific foundation, innovation, and implementation approach
• Evidence of analytical performance, clinical utility, adoption, or measurable impact
• Ability to support responsible use across real-world research or care settings
• Clear differentiation within the genomics and precision medicine landscape

Eligibility

• Open to companies, startups, organizations, and teams operating in health technology worldwide
• Entries should highlight work developed, released, updated, expanded, or significantly advanced during 2027
• Submissions should include supporting evidence that clearly demonstrates the innovation’s value and impact

Entry fees are charged at submission and are non-refundable. Customer or client identity should be included in your submission. If you need names excluded from public materials, notify us in writing at the time of submission. By submitting, you agree to the Submission Guidelines, Privacy Policy, and Terms and Conditions. HealthTechNode Awards are independent and unaffiliated with other award programs.